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The E2 protein of high risk human papillomavirus type 16 (HPV16) contains an amino-terminal (N) domain, a hinge (H) region and a
carboxyl-terminal (C) DNA-binding domain. Using enhanced green fluorescent protein (EGFP) fusions with full length E2 and E2 domains in
transfection assays in HeLa cells, we found that the C domain is responsible for the nuclear localization of E2 in vivo, whereas the N and H
domains do not contain additional nuclear localization signals (NLSs). Deletion analysis of EGFP-E2 and EGFP-cE2 determined that the C
domain contains an α helix cNLS that overlaps with the DNA-binding region. Mutational analysis revealed that the arginine and lysine residues in
this cNLS are essential for nuclear localization of HPV16 E2. Interestingly, these basic amino acid residues are well conserved among the E2
proteins of BPV-1 and some high risk HPV types but not in the low risk HPV types, suggesting that there are differences between the NLSs and
corresponding nuclear import pathways between these E2 proteins.
© 2006 Elsevier Inc. All rights reserved.Keywords: Human papillomavirus; E2 protein; NLSThe papillomavirus E2 proteins have major functions during
the viral life cycle in the regulation of viral DNA replication
together with E1 and in transcriptional activation or repression.
E2 can function either as an activator of viral transcription at low
concentrations or as a repressor at high concentrations when it
interferes with the binding of transcription factors such as TFIID
and Sp1 (reviewed in Longworth and Laimins, 2004). In
addition, E2 plays an essential role in viral genome segregation
by tethering the viral DNA to the mitotic chromosomes, and in
the case of bovine papillomavirus (BPV) type 1 E2 protein, this
process is mediated by the bromodomain protein Brd4 (Baxter
et al., 2005; McBride et al., 2004; McPhillips et al., 2005;
Oliveira et al., 2006; You et al., 2004). The high risk types
HPV16 and 18 E2 proteins have also proapoptotic activities
(Demeret et al., 2003; Webster et al., 2000). For HPV18 E2, this
proapoptotic activity depends on the induction of the extrinsic
pathway via caspase 8 activation in the cytoplasm (Blachon et
al., 2005; Demeret et al., 2003). Recently, the high risk HPV16/
18 E2 proteins, but not the low risk types, have been shown to
have the ability to induce genomic instability via a strong⁎ Corresponding author. Fax: +1 617 552 2011.
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doi:10.1016/j.virol.2006.10.018interaction with two activators of the Anaphase Promoting
Complex (APC), Cdc20 and Cdh1 (Bellanger et al., 2005).
The full length E2 protein contains two functional domains
connected by a flexible hinge (H) region and forms dimers via
the C-terminal domain. The structures of both the N-terminal
and C-terminal domains have been determined: the N domain
consists of a bundle of α helices packed against a β-sheet
framework (Harris and Botchan, 1999), whereas the C-DNA-
binding domain consists of a dimeric β-barrel structure with a
pair of symmetrically disposed α helices that bind and bend the
DNA (Hegde and Androphy, 1998; Hegde et al., 1992; Kim
et al., 2000). The N domain functions as a transactivation
domain and can also recruit and bind the E1 helicase. The
structure and functions of the N and C domains are relatively
conserved among papillomaviruses, whereas the H region is
variable both in sequence and length. Alternative promoter
usage and mRNA splicing generate additional forms of the E2
polypeptides that contain intact H and C domains and either a
truncated or substituted N domain (reviewed in Longworth and
Laimins, 2004).
Nucleocytoplasmic transport occurs through the nuclear pore
complex, which is a large structure with an eight-fold symmetry.
Nuclear import of macromolecules is signal-mediated, energy-
Fig. 1. Nuclear localization of HPV16 E2 and its C domain in vivo. HeLa cells
were transfected with either EGFP-E2 (A and B), or EGFP-nhE2 (C and D), or
EGFP-cE2 (E and F), or EGFP (G and H) plasmids and examined by
fluorescence microscopy at 24 h post transfection. Panels A, C, E and G
represent the fluorescence of the EGFP and panels B, D, F and H the DAPI
staining of the nuclei. Note the nuclear localization of EGFP-E2 and EGFP-cE2
(A and E).
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localization signals (NLSs), referred to as classical NLSs, fall
into two categories: monopartite NLSs consisting of a simple
sequence of 3–5 basic amino acid residues, and bipartite NLSs
consisting of a basic dipeptide upstream (10–12 amino acids)
from a simple basic sequence. Other types of NLSs have been
identified in hnRNP proteins, ribosomal proteins, U snRNPs and
viral proteins, while many others remain to be characterized.
Most NLSs do not fit a well defined consensus, and for many, no
consensus has been proposed (reviewed in Fried and Kutay,
2003; Moroianu, 1999). Two NLSs have been identified in the
BPV-1 E2 protein: residues 107 to 115 (RKCFKKGAR) in the N
domain and residues 339–352 (KCYRFRVKKNHRHR) in the
C domain (Skiadopoulos and McBride, 1996). Partially
homologous sequences are present in the E2 proteins of HPV
types, although it is not clear if they actually function as NLSs.
The E2 protein of low risk type HPV11 has been shown to
contain a classic monopartite NLS in the hinge region, required
for nuclear localization of HPV11 E2 and for its interaction with
the nuclear matrix (Zou et al., 2000). This HPV11 E2′NLS is not
conserved in the high risk HPV16 and HPV18 E2 proteins. In
this study, we have identified and characterized the NLS of high
risk HPV16 E2 protein using both in vivo and in vitro analysis of
the intracellular localization of E2, E2 domains and different
deletion and substitution variants.
Results
The C domain of HPV16 E2 is required for E2 nuclear
localization in vivo
To determine the E2 domain(s) that mediates the nuclear
localization of HPV16 E2, we generated EGFP fusion proteins
containing either the full length E2 or the N domain together
with the hinge (called nhE2) or the C domain (called cE2). HeLa
cells were transiently transfected with either EGFP-E2, EGFP-
nhE2, EGFP-cE2 or EGFP itself, and after 24 h, the intracellular
localization of the corresponding EGFP fusion proteins was
examined by fluorescence microscopy. EGFP-E2 had strong
nuclear localization, whereas EGFP itself was diffusely
localized throughout the cell (Figs. 1A and G). The EGFP-
cE2 had a similar nuclear localization as the full length E2,
whereas the EGFP-nhE2 was mostly cytoplasmic (Figs. 1E and
C). Note that, although the EGFP is small enough to passively
diffuse through the nuclear pore complex, the EGFP-E2 and
EGFP-cE2 (both as dimers) are above the limit of passive
diffusion and their nuclear localization requires NLS(s).
Immunoblot analysis with an anti-GFP antibody of the
translated EGFP-nhE2 and EGFP-cE2 fusion proteins indicated
that they were intact (data not shown), excluding the possibility
that the cytoplasmic localization of EGFP-nhE2 is due to
protein degradation. These data suggest that the C domain is
responsible for the nuclear localization of HPV16 E2 and that
the N domain and hinge region do not contain additional NLSs.
Note that in some cells the nuclear localization of EGFP-E2 and
EGFP-cE2 showed some accumulation in sub-nuclear struc-
tures that are most likely nucleoli (Figs. 1A and E). NucleolarGFP fluorescence has been previously observed with GFP-E2
proteins from both the high risk types (16 and 18) and low risk
types (6 and 11) (Blachon et al., 2005).
To investigate if the C domain can mediate active nuclear
import, we made a GST-cE2 fusion protein and tested it in in
vitro nuclear import assays. Digitonin-permeabilized HeLa
cells were incubated with either GST-cE2 or GST-NLS16L1 (as
a positive control) or GST (as a negative control) in the
presence of either only transport buffer or exogenous HeLa
cytosol. Both the GST-cE2 and GST-NLS16L1 were efficiently
imported into the nucleus in the presence of cytosol (Figs. 2B
and D), whereas the GST itself was not (Fig. 2F). These data
show that the C domain of HPV16 E2 can mediate active
nuclear import of a GST reporter indicating the presence of a
strong NLS. GST-cE2 was not imported in the absence of
Fig. 3. Deletion of a potential cNLS located in the C domain leads to cytoplasmic
mislocalization of HPV16 E2 in both HeLa and COS-1 cells. HeLa cells (A) or
COS-1 cells (B) were transfected with either EGFP-E2 (panels A and B) or
EGFP-E2ΔcNLS (panels C and D) plasmids and examined by fluorescence
microscopy at 24 h post transfection. Panels A and C represent the fluorescence
of the EGFP and panels B and D the DAPI staining of the nuclei.
Fig. 2. Nuclear import of the C domain of E2 in in vitro assays in digitonin-
permeabilized cells. Digitonin-permeabilized HeLa cells were incubated with
either GST-cE2 (A and B), or GST-NLS16L1 (C and D), or GST, as a negative
control (E and F) in the presence of either only transport buffer (A, C and E) or
HeLa cytosol (B, D and F). Nuclear localization of the GST fusion proteins was
detected by immunofluorescence microscopy with an anti-GST antibody. Note
the nuclear import of GST-cE2 and GST-NLS16L1 in panels B and D.
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mediated by nuclear import receptor(s).
An α helix NLS located in the C domain mediates HPV16 E2
nuclear import
It has been previously shown that, in addition to an NLS
located in the N domain, BPV1 E2 contains a cNLS
(KCYRFRVKKNHRHR) in the C domain (Skiadopoulos and
McBride, 1996). This cNLS is only partially conserved in
HPV16 E2 protein (298LKCLRYRFKKH308). To test if this
potential cNLS is required for nuclear localization of HPV16
E2, we generated a deletion mutant, EGFP-E2ΔcNLS lacking
this sequence. Analysis of the intracellular localization of
EGFP-E2ΔcNLS after transfection of HeLa cells revealed that
the deletion mutant is mislocalized in the cytoplasm in contrast
to the wild type EGFP-E2 which is in the nucleus (Fig. 3A,
compare panel C and A). Moreover, the same cytoplasmic
localization of EGFP-E2ΔcNLS versus nuclear localization of
EGFP-E2 was obtained after transfection of COS-1 cells (Fig.
3B, compare panel C and A). Immunoblot analysis with an anti-
GFP antibody of the expressed EGFP-E2 and EGFP-E2ΔcNLS
revealed that the proteins were intact and not degraded (data not
shown) indicating that the cytoplasmic localization of EGFP-
E2ΔcNLS is not due to degradation. Deletion of the cNLS alsoled to the cytoplasmic mislocalization of the C domain upon
transfection of HeLa cells with the EGFP-cE2ΔcNLS expres-
sion plasmid (Fig. 4A, compare panel C and A). Together, these
data suggest that the cNLS (298LKCLRYRFKKH308) is
required for nuclear localization of HPV16 E2 and that there
are no additional NLSs present in this E2 protein.
To determine if the cNLS is sufficient for active nuclear
import, we made a GST-cNLS fusion protein and tested it in
nuclear import assays. Digitonin-permeabilized HeLa cells
were incubated with either GST-cNLS or GST-NLS16L1 or GST
in the presence of either transport buffer or HeLa cytosol.
Although the GST-cNLS was imported into the nucleus in the
presence of cytosol, the efficiency of import was reduced in
comparison with the GST-NLS16L1 (Fig. 5, compare panel B
and D) or GST-cE2 (Fig. 2B).
Fig. 4. Deletion of the cNLS leads to cytoplasmic mislocalization of the C
domain of HPV16 E2. HeLa cells were transfected with either EGFP-cE2
(A and B) or EGFP-cE2ΔcNLS (C and D) plasmids and examined by
fluorescence microscopy at 24 h post transfection. Panels A and C represent the
fluorescence of the EGFP and panels B and D the DAPI staining of the nuclei.
Note the cytoplasmic localization of the EGFP-cE2ΔcNLS (C).
Fig. 5. Analysis of the nuclear import of GST-cNLS in digitonin-permeabilized
cells. Digitonin-permeabilized HeLa cells were incubated with either GST-
cNLSE2 (A and B), or GST-NLS16L1 (C and D), or GST (E and F) in the presence
of either only transport buffer (A, C and E) or HeLa cytosol (B, D and F).
Nuclear localization of the GST fusion proteins was detected by immuno-
fluorescence microscopy with an anti-GST antibody.
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nuclear localization, we generated the following alanine and
glutamic acid substitutions of the basic residues in the cNLS (in
bold) in the context of both EGFP-E2 and EGFP-cE2:
LKCLAAAFKKH (called sb1), LKCLRYRFAAH (called
sb2), LKCLEEEFKKH (called sb3) and LKCLRYRFEEH
(called sb4). We then analyzed the effect of these mutations on
the intracellular localization of EGFP-E2 and EGFP-cE2 after
transient transfection of HeLa cells.
The sb1 mutation in the cNLS (RYR to AAA) inhibited the
nuclear localization of both E2 and the cE2 domain, leading to a
diffuse localization throughout the cell of the EGFP-E2(sb2)
and EGFP-cE2(sb2) mutants (Figs. 6A and B, panels C), in
contrast with the nuclear localization of EGFP-E2 and EGFP-
cE2 (Figs. 6A and B, panels A). The sb2 mutation in the cNLS
(KK to AA) disrupted the nuclear localization of E2 leading
to mostly cytoplasmic mislocalization of the EGFP-E2(sb2)
(Fig. 7C). Surprisingly, when we analyzed the intracellular
localization of EGFP-cE2(sb2) in comparison with the wild
type EGFP-cE2 in HeLa cells, there was only a modest effect of
the sb2 mutation on the nuclear localization of EGFP-cE2(sb2)
(Fig. 7, compare panel G and E).
Substitutions of either the RYR or KK residues to glutamic
acid residues completely disrupted the nuclear localization of
E2 leading to cytoplasmic mislocalization of the EGFP-E2(sb3)
and EGFP-E2(sb4) in HeLa cells (Figs. 8B and C).
Discussion
In this study, we have identified a cNLS (298LKCLRYRF-
KKH308) located in the C domain that is essential for the nuclear
localization of HPV16 E2 protein in vivo. HPV16 E2′ cNLS
overlaps with the α recognition helix which contains the aminoacids involved in the interaction with the DNA (Hegde and
Androphy, 1998). Using mutational-function analysis in vivo,
we determined that both the RYR motif and the KK residues in
the cNLS (298LKCLRYRFKKH308) are critical for the nuclear
localization of HPV16 E2. The difference in the effect of the
mutations of KK to AA in the cNLS on the intracellular
localization of the EGFP-cE2(sb2) (mostly nuclear) versus
EGFP-E2(sb2) (mostly cytoplasmic) could be due to the fact that
these substitutions may impair cE2 dimerization. In such a case,
the EGFP-cE2(sb2) (as a monomer) would be below the passive
diffusion limit of the nuclear pore complex and may enter the
nucleus even with a defective NLS, whereas the dimeric EGFP-
E2 is above this limit and requires a functional NLS.
Interestingly, the K residues are conserved in the E2 proteins
of BPV-1 and some high risk HPV types (16, 18, 45 and 70)
(Table 1) but not in other high risk HPV types (such as 31, 33, 52
and 56). These basic K residues are also not conserved in the
low risk HPV E2 proteins; in the HPV11 E2 and HPV6A/6B
E2, the KK residues are substituted with ND residues (Table
1). This correlates with the finding that in HPV11 E2 the
sequence (LKCFRYRLND) does not function in nuclear
localization of E2; instead, HPV11 E2 contains a classical
monopartite NLS (hNLS=RKRAR) located in the H region
that mediates nuclear localization of this E2 protein (Zou
et al., 2000). This hNLS is conserved in other low risk types,
but not in the high risk types HPV16 and 18 E2 proteins (Zou
Fig. 6. Mutational-function analysis of the cNLS ofHPV16 E2 in vivo. HeLa cells
were transfected with either EGFP-E2 (A, panels A and B), or EGFP-E2(sb1) (A,
panels C andD), or EGFP-cE2 (B, panels A and B), or EGFP-cE2(sb1) (B, panels
C and D), or EGFP (B, panels E and F) plasmids and examined by fluorescence
microscopy at 24 h post transfection. Panels A, C, and E represent the
fluorescence of the EGFP and panels B, D and F the DAPI staining of the nuclei.
Fig. 7. Mutational-function analysis of the cNLS of HPV16 E2 in vivo. HeLa
cells were transfected with either EGFP-E2 (panels A and B), or EGFP-E2(sb2)
(panels C and D), or EGFP-cE2 (panels E and F), or EGFP-cE2(sb2) (panels G
and H), or EGFP (panels J and K) plasmids and examined by fluorescence
microscopy at 24 h post transfection. Panels A, C, E, G and J represent the
fluorescence of the EGFP and panels B, D, F, H and K the DAPI staining of the
nuclei.
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and hinge region of HPV16 E2. The E2 protein of BPV-1
contains a similar α helix cNLS located in the C domain
(Table 1) which is conserved among fibropapillomaviruses
(Skiadopoulos and McBride, 1996). BPV-1 E2 contains also
an NLS located in the N domain (nNLS=RKCFKKGAR)(Skiadopoulos and McBride, 1996) which is not conserved in
either the high risk HPV16 E2 or the low risk HPV11 E2. The
difference in the NLSs of different papillomavirus E2 proteins
suggests that they use different karyopherins/importins and
nuclear import pathways.
Although the α helix cNLS is essential for nuclear
localization of HPV16 E2, we cannot exclude the possibility
Fig. 8. Effect of substitutions of basic amino acids to glutamic acid in the cNLS on HPV16 E2 nuclear localization. HeLa cells were transfected with either EGFP-E2
(A and D), or EGFP-E2(sb3) (B and E), or EGFP-E2(sb4) (C and F) plasmids and examined by fluorescence microscopy at 24 h post transfection. Panels A–C
represent the fluorescence of the EGFP and panels D–F the DAPI staining of the nuclei. Note the nuclear localization of EGFP-E2 in panel A, and the cytoplasmic
localization of EGFP-E2(sb3) and EGFP-E2(sb4) variants in panels B and C.
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the complete cNLS function. In this respect, the nuclear import
of the GST-cNLS in digitonin-permeabilized cells was less
efficient than that of the GST-cE2. At least two reasons, which
are not exclusive, could account for this: (1) additional residues
are involved in the cNLS function and (2) most likely the α
helix structure of the cNLS is not maintained when isolated out
of the E2 protein context and may be essential for the interaction
with the corresponding nuclear import receptor.
The E2 proteins exist in solution and bind to DNA as dimers.
However, it is not clear if in the cell they dimerize in the
cytoplasm and enter the nucleus as dimers or they enter as
monomers and dimerize in the nucleus. In the first case,
dimerization will lead to the presence of two NLSs which may
function cooperatively in the nuclear import of E2.
Although the cNLS of HPV16 E2 contains basic residues
and has sequence resemblance with classical monopartite NLSs,
it is different in its structure as it is an α helix, whereas the
classical NLSs bind to the karyopherins α in an extended
conformation, as shown by structural studies (Chook and
Blobel, 2001). The transcription factor PacC from the fungus
Aspergillus nidulans also contains an α helix NLS that overlaps
with the DNA-binding residues within the zinc finger domain of
PacC (Fernandez-Martinez et al., 2003). Although the PacC's
NLS contains basic residues and resembles in sequence a
monopartite NLS, it does not interact with the A. nidulansTable 1







BPV1 E2 VKCYRFRVKKNHRHRimportin α (Fernandez-Martinez et al., 2003). Future studies
will lead to the identification of the nuclear import receptor(s)
for the α helix cNLS of HPV16 E2 protein and the biochemical
characterization of this nuclear import pathway.
Materials and methods
Generation of EGFP-E2, EGFP-nhE2 and EGFP-cE2
plasmids and mutagenesis
The enhanced green fluorescent protein (EGFP) expression
plasmid pEGFP-C1 (Clontech, Inc.) was used to construct the
EGFP fusion protein expression plasmids (EGFP-E2, EGFP-
cE2, GFP-E2ΔcNLS, EGFP-cE2ΔcNLS (Fig. 9) as follows.
The pEGFP-C1 plasmid was double digested with EcoRI and
SalI, run on a 0.7% agarose gel and the digested vector was
extracted using the protocol from the QIAquick Gel Extraction
Kit (Qiagen). DNA fragments spanning the full length HPV16
E2 or the C domain (cE2), or E2ΔcNLS, cE2ΔcNLS (lacking
the potential cNLS, aa 298–308) were amplified using PCR
oligonucleotides that added EcoRI and SalI restrictionFig. 9. Schematic representation of deletion and substitution mutants of HPV16
E2 and its C domain used to make EGFP fusion proteins.
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EcoRI and SalI restriction enzymes and then ligated using T4
DNA ligase into the EcoRI and SalI cloning sites of pEGFP-
C1. The resulting plasmids were used to transform XL1-Blue
cells, and the purified plasmids were confirmed by sequencing
(MGH DNA Sequencing Department).
The EGFP-nhE2 (containing the N domain and H region of
E2, aa 1–284) was generated using the QuikChange™ Site-
Directed Mutagenesis Kit from Stratagene and mutated primers
containing a stop codon at aa 285. The EGFP fusions
containing mutations of the cNLS: EGFP-E2(sb1, substitution
of RYR with AAA), EGFP-E2(sb2, substitution of KK with
AA), EGFP-cE2(sb1), EGFP-cE2(sb2) (see Fig. 9), E2(sb3,
substitution of RYR with EEE) and EGFP-E2(sb4, substitution
of KK with EE), were generated using the QuikChange™ Site-
Directed Mutagenesis Kit and the corresponding mutated
primers. The constructs were used to transform XL1 blue
bacteria, and the purified plasmids were confirmed by sequence
analysis (MGH DNA Sequencing Department). The different
E2 proteins used to make EGFP fusions are schematically
represented in Fig. 9.
Preparation of GST-cE2 and GST-cNLS
The GST-cNLSE2 fusion protein construct was prepared by
fusing the cNLS sequence (298LKCLRYRFKKH308) to a GST
reporter. To make the GST-cNLS construct, the corresponding
forward and reverse oligonucleotides containing an EcoRI and
XhoI restriction-cutting sites were annealed and inserted directly
into the pGEX4T-1 vector which had been double cut with the
same enzymes. The GST-cE2 construct was generated by
inserting the PCR amplified cE2 fragment containing EcoRI
and XhoI sites into the pGEX4T-1 vector which had been
double cut with the same enzymes. Both the GST-cNLS and
GST-cE2 constructs were transformed in XL1 blue bacteria and
confirmed by automated sequence analysis (MGH DNA
sequencing department). For protein expression, the GST-
cNLS and GST-cE2 constructs were used to transform E. coli
BL21 CodonPlus. After induction of the bacteria with 1 mM
IPTG for 2 h at 30 °C, the GST-cNLS and GST-cE2 fusion
proteins were purified in native state on glutathione–Sepharose
beads using a standard procedure. The GST-NLSHPV16L1 con-
taining the monopartite NLS (AKRKKRKL) of HPV16 L1
major capsid protein was prepared as previously described
(Nelson et al., 2003). The proteins were checked for purity and
lack of proteolytic degradation by SDS-PAGE and Coomassie
Blue staining. The purified proteins were dialyzed in transport
buffer (20 mM HEPES-KOH, pH 7.3, 110 mM potassium
acetate, 2 mM magnesium acetate, 1 mM EGTA, 2 mM DTT,
plus protease inhibitors) and stored in aliquots at −80 °C until
use.
Transient expressions and fluorescence microscopy
HeLa cells (ATCC) and COS-1 cells (ATCC) were plated
on 12 mm poly-L-lysine-coated glass coverslips to 50–70%
confluency 24 h prior to transfection. Cells in each well weretransfected with the corresponding EGFP-E2 plasmids (as
indicated in figure legends) and FUGENE 6 (Roche Applied
Science, IN) in 500 μl DMEM prepared following product
protocol. Media was changed to DMEM with 10% FBS and
pen–strep after 6 h, and the cells were fixed 24 h after the
initial transfection with 10% formaldehyde in PBS (10 min).
Coverslips were mounted using Vectashield-Dapi mounting
medium (Vector Labs, CA) to identify the nuclei by DAPI
staining and examined by fluorescence microscopy using a
Nikon Eclipse TE 300 Microscope. All images were taken at
the same exposure with a Sony DKC-5000 camera. The
lower cytoplasmic level of the expressed EGFP-E2ΔcNLS
and EGFP-cE2ΔcNLS (Figs. 3 and 4) could be due to either
lower expression or less stability of these proteins when they
are located in the cytoplasm. We did not notice that the
EGFP-E2 fusion proteins induce apoptosis of the transfected
HeLa cells in our conditions. This is in agreement with
previous results where apoptosis was detectable only in
cells infected at higher m.o.i. of HPV18 and HPV16 GFP
E2-expressing recombinant adenoviruses (Blachon et al.,
2005).
Nuclear import assays
The nuclear import assays were carried out as previously
described (Nelson et al., 2002). Briefly, subconfluent HeLa
cells, grown on poly-L-lysine coated glass coverslips for 24 h,
were permeabilized with 70 μg/ml digitonin for 5 min on ice
and washed with cold transport buffer. All import reactions
contained an energy regenerating system (1 mM GTP, 1 mM
ATP, 5 mM phosphocreatine and 0.4 U creatine phosphoki-
nase), HeLa cytosol, and the different GST-fusion proteins (as
indicated in the figure legends). Final import reaction volume
was adjusted to 20 μl with transport buffer. For visualization of
nuclear import, the GST fusion proteins were detected by
immunofluorescence with an anti-GST antibody, as previously
described (Nelson et al., 2002). Coverslips were mounted using
Vectashield-Dapi mounting medium (Vector Labs, CA) to
identify the nuclei by DAPI staining. Nuclear import was
analyzed with a Nikon Eclipse TE 300 Microscope that has a
fluorescence attachment and a Sony DKC-5000 CCD camera.
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